시장보고서

상품코드

1652023

세계의 당뇨병 기기 시장 : 시장 규모, 점유율 및 동향, 업계 분석 - 유형별, 유통 채널별, 최종 용도별, 지역별, 예측(2025-2034년)

Diabetes Devices Market Size, Share, Trends, Industry Analysis Report: By Type, Distribution Channel, End Use, and Region - Market Forecast, 2025-2034

발행일: 2025년 01월 | 리서치사:

Polaris Market Research | 페이지 정보: 영문 125 Pages | 배송안내 : 1-2일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

Polaris Market Research의 최신 조사에 따르면 세계의 당뇨병 기기 시장 규모는 2034년까지 673억 9,000만 달러에 이를 전망입니다. 이 보고서는 현재 시장 역학을 상세하게 파악하고 미래 시장 성장에 대한 분석을 제공합니다.

당뇨병 기기는 당뇨병을 앓고 있는 사람들의 혈당 모니터링 및 유지, 심각한 합병증의 예방, 일반적인 생활의 질 향상을 지원합니다. 이러한 적극적인 접근법은 질병 관리를 강화하고, 환자의 결과를 개선하며, 이러한 장비가 환자 관리의 진보를 이루는 중요한 역할을 명확히 합니다. 당뇨병 기기 시장 수요를 견인하고 있는 것은 당뇨병 기기에 의한 입원이나 사망률의 감소 효과입니다.

인공지능(AI) 및 머신러닝(ML)과 같은 첨단 기술이 당뇨병 기기에 통합되어 있는 것은 당뇨병 기기 시장의 수익 확대에 크게 기여하고 있습니다. AI와 ML은 근본적인 위험 인자를 확인하고, 위험 합병증을 예측하고, 당뇨병 망막증 및 신증과 같은 당뇨병 관련 질환을 예방하기 위한 개입을 제안하는 데 도움이 됩니다. 이러한 기술은 또한 생활 습관 관리 개선, 긍정적인 임상 판단 촉진, 환자 참여 향상에 중요한 역할을 합니다. 예를 들어, 2024년 8월에 National Library of Medicine에 게재된 연구는 AI와 머신러닝이 당뇨병 관리에 점점 활용되고 있으며, 예측 정확도, 개인화된 치료 전략, 전반적인 환자 결과, 건강 효율성을 크게 개선하고 있다고 강조하고 있습니다.

당뇨병 기기 제조업체는 노인 인구의 많음, 저렴한 건강 관리, 비용 효율적인 노동력, 규제 완화 등의 요인으로 신흥 시장 진출을 확대하고 있습니다. 시장 진출 기업은 수요 증가에 대응하기 위해 첨단 인슐린 펌프 및 펜과 같은 기술적 진보를 활용하고 있습니다. 예를 들어, 2022년 6월, Abbott는 새로운 지속 포도당 케톤 모니터링 시스템을 출시하여 시장에서의 입지를 더욱 강화했습니다.

당뇨병 기기 시장 : 분석 개요

유형별로는 인슐린 투여 장치 분야가 2024년 당뇨병 기기 시장 점유율을 독점했습니다. 이 부문의 견조한 성장은 인슐린 패치, 펌프, 자동 인슐린 전달(AID) 시스템과 같은 상당한 기술 발전으로 인한 것입니다.

유통 채널별로 병원 약국 부문은 2024년 매출 점유율 56.33%로 시장을 선도했습니다. 이는 환자 수가 많아 병원 약국에서 혁신적인 신제품을 사용할 수 있기 때문입니다.

북미는 2024년 수익 점유율 41.80%로 당뇨병 기기 시장을 독점했습니다. 고령화 인구 증가, 라이프스타일 변화로 인한 당뇨병 유병률 증가, 비만 유병률 증가 등 다양한 요인들이 이 지역 시장 성장에 기여하고 있습니다.

아시아태평양의 당뇨병 기기 시장은 예측 기간 동안 7.45%의 상당한 CAGR을 나타낼 것으로 예상됩니다. 이 지역 시장 성장의 원동력은 대기업의 존재와 당뇨병 이환율의 상승입니다. 게다가, 혈당 모니터링 기술의 진보는 예측 기간 동안 이 지역 시장 확대를 촉진할 것으로 기대됩니다.

이 시장의 주요 기업의 일례로 Abbott Diabetes Care, B Braun Melsungen AG, Biocorp, DexCom, Johnson & Johnson, GlucoModicum, LifeScan, Medtronic PLC, Molex, Novo Nordisk, Diabetes Care사 등을 들 수 있습니다.

시장 현황
당뇨병 기기 시장 역학
- 성장 촉진요인 및 기회
  - 신흥국에서 당뇨병 이환율의 상승
  - 당뇨병 기기의 기술 진보
- 억제요인 및 과제
  - 기기의 고비용
PESTLE 분석
당뇨병 기기 시장 동향
밸류체인 분석
COVID-19의 영향 분석

제5장 세계의 당뇨병 기기 시장 : 유형별

주요 분석 결과
서문
BGM(혈당 모니터링) 기기
인슐린 투여 기기

제6장 세계의 당뇨병 기기 시장 : 유통 채널별

주요 분석 결과
서문
병원 약국
소매 약국
당뇨병 클리닉 및 센터
온라인 약국
기타

제7장 세계의 당뇨병 기기 시장 : 최종 용도별

주요 분석 결과
서문
병원
진단센터
재택치료

제8장 세계의 당뇨병 기기 시장 : 지역별

주요 분석 결과
서문
- 당뇨병 기기 시장의 평가 : 지역별(2020-2034년)
북미
- 북미 : 유형별(2020-2034년)
- 북미 : 유통 채널별(2020-2034년)
- 북미 : 최종 용도별(2020-2034년)
- 미국
- 캐나다
유럽
- 유럽 : 유형별(2020-2034년)
- 유럽 : 유통 채널별(2020-2034년)
- 유럽 : 최종 용도별(2020-2034년)
- 영국
- 프랑스
- 독일
- 이탈리아
- 스페인
- 네덜란드
- 러시아
- 기타 유럽
아시아태평양
- 아시아태평양 : 유형별(2020-2034년)
- 아시아태평양 : 유통 채널별(2020-2034년)
- 아시아태평양 : 최종 용도별(2020-2034년)
- 중국
- 인도
- 말레이시아
- 일본
- 인도네시아
- 한국
- 호주
- 기타 아시아태평양
중동 및 아프리카
- 중동 및 아프리카 : 유형별(2020-2034년)
- 중동 및 아프리카 : 유통 채널별(2020-2034년)
- 중동 및 아프리카 : 최종 용도별(2020-2034년)
- 사우디아라비아
- 아랍에미리트(UAE)
- 이스라엘
- 남아프리카
- 기타 중동 및 아프리카
라틴아메리카
- 라틴아메리카 : 유형별(2020-2034년)
- 라틴아메리카 : 유통 채널별(2020-2034년)
- 라틴아메리카 : 최종 용도별(2020-2034년)
- 멕시코
- 브라질
- 아르헨티나
- 기타 라틴아메리카

제9장 경쟁 구도

사업 확대 및 기업 인수 분석
- 사업 확대
- 기업 인수
제휴, 협업, 합의 및 공개

제10장 기업 프로파일

Abbott Diabetes Care
B Braun Melsungen AG
Biocorp
DexCom, Inc.
Johnson & Johnson
GlucoModicum
LifeScan Inc.
Medtronic PLC
Molex
Novo Nordisk
Phillips-Medisize
Roche Diabetes Care
Senseonics, Inc.
Tandem Diabetes Care, Inc.

AJY 25.03.12

The global diabetes devices market size is expected to reach USD 67.39 billion by 2034, according to a new study by Polaris Market Research. The report "Diabetes Devices Market Size, Share, Trends, Industry Analysis Report: By Type, Distribution Channel, End Use (Hospitals, Diagnostic Centers, and Homecare), and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Diabetes devices help people suffering from diabetes monitor and maintain blood sugar levels, prevent severe complications, and generally improve the quality of life. This proactive approach enhances disease management, improves patient outcomes, and underscores the significant role these devices play in advancing patient care. The diabetes devices market demand is driven by the effectiveness of diabetes devices in reducing hospitalizations and mortality rates.

The incorporation of advanced technologies such as artificial intelligence (AI) and machine learning (ML) in diabetes devices majorly contributes to the growing diabetes devices market revenue. AI and ML help identify underlying risk factors, predict risk complications, and suggest interventions to prevent diabetes-related conditions, such as diabetic retinopathy and nephropathy. These technologies also play a crucial role in improving lifestyle management, fostering positive clinical decisions, and increasing patient engagement. For instance, a study published in the National Library of Medicine in August 2024 highlights how AI and machine learning are being increasingly utilized in diabetes management, significantly improving predictive accuracy, personalized treatment strategies, overall patient outcomes, and healthcare efficiency.

Diabetes device manufacturers are expanding their presence into emerging markets due to factors such as a large elderly population, affordable healthcare, cost-effective labor, and less stringent regulations. Market participants are also capitalizing on technological advancements, including advanced insulin pumps and pens, to cater to the rising demand. For instance, in June 2022, Abbott launched a new continuous glucose and ketone monitoring system, further strengthening its position in the market.

Key Highlights of Diabetes Devices Market Report

Based on type, the insulin delivery devices segment dominated the diabetes devices market share in 2024. The segment's robust growth is attributed to significant technological advancements, such as insulin patches, pumps, and automated insulin delivery (AID) systems.

Based on distribution channel, the hospital pharmacies segment led the market with a revenue share of 56.33% in 2024. This is due to the high volume of patients and the availability of new innovative products in hospital pharmacies.

North America dominated the diabetes devices market with a revenue share of 41.80% in 2024. Various factors such as an rising aging population, increasing incidence of diabetes due to lifestyle changes, and growing prevalence of obesity contribute to the regional market growth.

The Asia Pacific diabetes devices market is expected to register a significant CAGR of 7.45% during the forecast period. The market growth in the region is driven by the presence of leading players and a rising incidence of diabetes. Additionally, advancements in blood glucose monitoring technology are expected to propel market expansion in the region during the forecast period.

A few of the key players in the market are Abbott Diabetes Care; B Braun Melsungen AG; Biocorp; DexCom, Inc.; Johnson & Johnson; GlucoModicum; LifeScan Inc.; Medtronic PLC; Molex; Novo Nordisk; Phillips-Medisize; Roche Diabetes Care; Senseonics, Inc.; and Tandem Diabetes Care, Inc.

Polaris Market Research has segmented the diabetes devices market report on the basis of type, distribution channel, end use, and region:

By Type Outlook (Revenue - USD Billion, 2020-2034)

BGM Devices
Self-Monitoring Devices
§ Blood Glucose Meters
§ Testing Strips
§ Lancets
Continuous Glucose Monitoring Devices
§ Sensors
§ Transmitters
§ Receiver
Insulin Delivery Devices
Pumps
Pens
Syringes
Jet Injectors

By Distribution Channel Outlook (Revenue - USD Billion, 2020-2034)

Hospital pharmacies
Retail Pharmacies
Diabetes Clinics/Centers
Online Pharmacies
Others

By End Use Outlook (Revenue - USD Billion, 2020-2034)

Hospitals
Diagnostic Centers
Homecare

By Regional Outlook (Revenue - USD Billion, 2020-2034)

North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of the Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Diabetes Devices Market Insights

4.1. Diabetes Devices Market - Market Snapshot
4.2. Diabetes Devices Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Rising Diabetes Prevalence in Developing Economies
  - 4.2.1.2. Technological Advancements in Diabetes Devices
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. High Cost of Devices
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry Among Existing Firms (High)
4.4. PESTEL Analysis
4.5. Diabetes Devices Market Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Diabetes Devices Market, by Type

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
5.3. BGM Devices
- 5.3.1. Global Diabetes Devices Market, by BGM Devices, by Region, 2020-2034 (USD Billion)
- 5.3.2. Self-Monitoring Devices
  - 5.3.2.1. Global Diabetes Devices Market, by Self-Monitoring Devices, by Region, 2020-2034 (USD Billion)
  - 5.3.2.2. Blood Glucose Meters
  - 5.3.2.2.1. Global Diabetes Devices Market, by Blood Glucose Meters, by Region, 2020-2034 (USD Billion)
  - 5.3.2.3. Testing Strips
  - 5.3.2.3.1. Global Diabetes Devices Market, by Testing Strips, by Region, 2020-2034 (USD Billion)
  - 5.3.2.4. Lancets
  - 5.3.2.4.1. Global Diabetes Devices Market, by Lancets, by Region, 2020-2034 (USD Billion)
- 5.3.3. Continuous Glucose Monitoring Devices
  - 5.3.3.1. Global Diabetes Devices Market, by Continuous Glucose Monitoring Devices, by Region, 2020-2034 (USD Billion)
  - 5.3.3.2. Sensors
  - 5.3.3.2.1. Global Diabetes Devices Market, by Sensors, by Region, 2020-2034 (USD Billion)
  - 5.3.3.3. Transmitters
  - 5.3.3.3.1. Global Diabetes Devices Market, by Transmitters, by Region, 2020-2034 (USD Billion)
  - 5.3.3.4. Receiver
  - 5.3.3.4.1. Global Diabetes Devices Market, by Receiver, by Region, 2020-2034 (USD Billion)
5.4. Insulin Delivery Devices
- 5.4.1. Global Diabetes Devices Market, by Insulin Delivery Devices, by Region, 2020-2034 (USD Billion)
- 5.4.2. Pumps
  - 5.4.2.1. Global Diabetes Devices Market, by Pumps, by Region, 2020-2034 (USD Billion)
- 5.4.3. Pens
  - 5.4.3.1. Global Diabetes Devices Market, by Pens, by Region, 2020-2034 (USD Billion)
- 5.4.4. Syringes
  - 5.4.4.1. Global Diabetes Devices Market, by Syringes, by Region, 2020-2034 (USD Billion)
- 5.4.5. Jet Injectors
  - 5.4.5.1. Global Diabetes Devices Market, by Jet Injectors, by Region, 2020-2034 (USD Billion)

6. Global Diabetes Devices Market, by Distribution Channel

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
6.3. Hospital Pharmacies
- 6.3.1. Global Diabetes Devices Market, by Hospital Pharmacies, by Region, 2020-2034 (USD Billion)
6.4. Retail Pharmacies
- 6.4.1. Global Diabetes Devices Market, by Retail Pharmacies, by Region, 2020-2034 (USD Billion)
6.5. Diabetes Clinics/Centers
- 6.5.1. Global Diabetes Devices Market, by Diabetes Clinics/Centers, by Region, 2020-2034 (USD Billion)
6.6. Online Pharmacies
- 6.6.1. Global Diabetes Devices Market, by Online Pharmacies, by Region, 2020-2034 (USD Billion)
6.7. Others
- 6.7.1. Global Diabetes Devices Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Diabetes Devices Market, by End Use

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
7.3. Hospitals
- 7.3.1. Global Diabetes Devices Market, by Hospitals, by Region, 2020-2034 (USD Billion)
7.4. Diagnostic Centers
- 7.4.1. Global Diabetes Devices Market, by Diagnostic Centers, by Region, 2020-2034 (USD Billion)
7.5. Homecare
- 7.5.1. Global Diabetes Devices Market, by Homecare, by Region, 2020-2034 (USD Billion)

8. Global Diabetes Devices Market, by Geography

8.1. Key Findings
8.2. Introduction
- 8.2.1. Diabetes Devices Market Assessment, by Geography, 2020-2034 (USD Billion)
8.3. Diabetes Devices Market - North America
- 8.3.1. North America: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
- 8.3.2. North America: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.3.3. North America: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
- 8.3.4. Diabetes Devices Market - US
  - 8.3.4.1. US: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  - 8.3.4.2. US: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.3.4.3. US: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
- 8.3.5. Diabetes Devices Market - Canada
  - 8.3.5.1. Canada: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  - 8.3.5.2. Canada: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.3.5.3. Canada: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
8.4. Diabetes Devices Market - Europe
- 8.4.1. Europe: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
- 8.4.2. Europe: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.4.3. Europe: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
- 8.4.4. Diabetes Devices Market - UK
  - 8.4.4.1. UK: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  - 8.4.4.2. UK: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.4.4.3. UK: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
- 8.4.5. Diabetes Devices Market - France
  - 8.4.5.1. France: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  - 8.4.5.2. France: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.4.5.3. France: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
- 8.4.6. Diabetes Devices Market - Germany
  - 8.4.6.1. Germany: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  - 8.4.6.2. Germany: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.4.6.3. Germany: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
- 8.4.7. Diabetes Devices Market - Italy
  - 8.4.7.1. Italy: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  - 8.4.7.2. Italy: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.4.7.3. Italy: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
- 8.4.8. Diabetes Devices Market - Spain
  - 8.4.8.1. Spain: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  - 8.4.8.2. Spain: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.4.8.3. Spain: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
- 8.4.9. Diabetes Devices Market - Netherlands
  - 8.4.9.1. Netherlands: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  - 8.4.9.2. Netherlands: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.4.9.3. Netherlands: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
- 8.4.10. Diabetes Devices Market - Russia
  - 8.4.10.1. Russia: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  - 8.4.10.2. Russia: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.4.10.3. Russia: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
- 8.4.11. Diabetes Devices Market - Rest of Europe
  - 8.4.11.1. Rest of Europe: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  - 8.4.11.2. Rest of Europe: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.4.11.3. Rest of Europe: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
8.5. Diabetes Devices Market - Asia Pacific
- 8.5.1. Asia Pacific: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
- 8.5.2. Asia Pacific: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.5.3. Asia Pacific: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
- 8.5.4. Diabetes Devices Market - China
  - 8.5.4.1. China: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  - 8.5.4.2. China: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.5.4.3. China: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
- 8.5.5. Diabetes Devices Market - India
  - 8.5.5.1. India: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  - 8.5.5.2. India: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.5.5.3. India: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
- 8.5.6. Diabetes Devices Market - Malaysia
  - 8.5.6.1. Malaysia: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  - 8.5.6.2. Malaysia: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.5.6.3. Malaysia: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
- 8.5.7. Diabetes Devices Market - Japan
  - 8.5.7.1. Japan: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  - 8.5.7.2. Japan: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.5.7.3. Japan: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
- 8.5.8. Diabetes Devices Market - Indonesia
  - 8.5.8.1. Indonesia: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  - 8.5.8.2. Indonesia: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.5.8.3. Indonesia: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
- 8.5.9. Diabetes Devices Market - South Korea
  - 8.5.9.1. South Korea: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  - 8.5.9.2. South Korea: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.5.9.3. South Korea: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
- 8.5.10. Diabetes Devices Market - Australia
  - 8.5.10.1. Australia: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  - 8.5.10.2. Australia: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.5.10.3. Australia: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
- 8.5.11. Diabetes Devices Market - Rest of Asia Pacific
  - 8.5.11.1. Rest of Asia Pacific: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  - 8.5.11.2. Rest of Asia Pacific: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.5.11.3. Rest of Asia Pacific: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
8.6. Diabetes Devices Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
- 8.6.2. Middle East & Africa: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.6.3. Middle East & Africa: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
- 8.6.4. Diabetes Devices Market - Saudi Arabia
  - 8.6.4.1. Saudi Arabia: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  - 8.6.4.2. Saudi Arabia: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.6.4.3. Saudi Arabia: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
- 8.6.5. Diabetes Devices Market - UAE
  - 8.6.5.1. UAE: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  - 8.6.5.2. UAE: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.6.5.3. UAE: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
- 8.6.6. Diabetes Devices Market - Israel
  - 8.6.6.1. Israel: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  - 8.6.6.2. Israel: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.6.6.3. Israel: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
- 8.6.7. Diabetes Devices Market - South Africa
  - 8.6.7.1. South Africa: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  - 8.6.7.2. South Africa: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.6.7.3. South Africa: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
- 8.6.8. Diabetes Devices Market - Rest of Middle East & Africa
  - 8.6.8.1. Rest of Middle East & Africa: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  - 8.6.8.2. Rest of Middle East & Africa: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.6.8.3. Rest of Middle East & Africa: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
8.7. Diabetes Devices Market - Latin America
- 8.7.1. Latin America: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
- 8.7.2. Latin America: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.7.3. Latin America: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
- 8.7.4. Diabetes Devices Market - Mexico
  - 8.7.4.1. Mexico: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  - 8.7.4.2. Mexico: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.7.4.3. Mexico: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
- 8.7.5. Diabetes Devices Market - Brazil
  - 8.7.5.1. Brazil: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  - 8.7.5.2. Brazil: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.7.5.3. Brazil: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
- 8.7.6. Diabetes Devices Market - Argentina
  - 8.7.6.1. Argentina: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  - 8.7.6.2. Argentina: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.7.6.3. Argentina: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
- 8.7.7. Diabetes Devices Market - Rest of Latin America
  - 8.7.7.1. Rest of Latin America: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  - 8.7.7.2. Rest of Latin America: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.7.7.3. Rest of Latin America: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)

9. Competitive Landscape

9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

10.1. Abbott Diabetes Care
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
10.2. B Braun Melsungen AG
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
10.3. Biocorp
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
10.4. DexCom, Inc.
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
10.5. Johnson & Johnson
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
10.6. GlucoModicum
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
10.7. LifeScan Inc.
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
10.8. Medtronic PLC
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
10.9. Molex
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
10.10. Novo Nordisk
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
10.11. Phillips-Medisize
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development
10.12. Roche Diabetes Care
- 10.12.1. Company Overview
- 10.12.2. Financial Performance
- 10.12.3. Product Benchmarking
- 10.12.4. Recent Development
10.13. Senseonics, Inc.
- 10.13.1. Company Overview
- 10.13.2. Financial Performance
- 10.13.3. Product Benchmarking
- 10.13.4. Recent Development
10.14. Tandem Diabetes Care, Inc.
- 10.14.1. Company Overview
- 10.14.2. Financial Performance
- 10.14.3. Product Benchmarking
- 10.14.4. Recent Development